Kinnate Biopharma clinical trials
Acquired by Ligand Pharmaceuticals Incorporated, Jul 14, 2026 · source ↗
The registry lists 1 studies whose lead sponsor is Kinnate Biopharma. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 7, 2025.
Before and after it joined Ligand Pharmaceuticals Incorporated
- First submitted before Kinnate Biopharma became part of Ligand Pharmaceuticals Incorporated
- 1
- First submitted after Kinnate Biopharma became part of Ligand Pharmaceuticals Incorporated
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Kinnate Biopharma1 study
Something wrong with this grouping? Tell us on the Ligand Pharmaceuticals Incorporated page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Ligand Pharmaceuticals Incorporated studies →
- A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene AlterationsTerminatedNCT05242822Phase 1
Sponsor listed in the registry: Kinnate Biopharma · First submitted before Kinnate Biopharma became part of Ligand Pharmaceuticals Incorporated